NEUMOLOGÍA PEDIÁTRICA

21 / 64

65 Contenido disponible en
35. Palerm-Caraballo L, González-Muñoz G, Savon-Valdés CE, Valdés
Ramírez O, González-Báez G, Goyenechea-Hernández J, et al.
Seroepidemiological surveillance of human parainfluenza viruses
(HPIVs) types 2 and 3 in an infantile population selected in Havana
City. Rev Cubana Med Trop 2005; 57: 169-74.
36. Luchsinger V. Características del virus influenza y diagnóstico de
laboratorio. Neumol Pediatr 2009; 4: 3-5.
37. Zamorano J, Budnik I. Manifestaciones clínicas de la infección por
virus influenza en niños inmunocompetentes. Neumol Pediatr
2009; 4: 14-8.
38. Lee BE, Robinson JL, Khurana V, Pang XL, Preiksaitis JK, Fox JD.
Enhanced identification of viral and atypical bacterial pathogens in
lower respiratory tract samples with nucleic acid amplification tests.
J Med Virol 2006; 78: 702-10.
39. García-García J, Ramos C. La influenza, un problema vigente de
salud pública. Salud Publica Mex 2006; 48: 244-67.
40. Martin AA, Moreno-Pérez D, Miguelez SA, Gianzo JA, García ML,
Murua JK, et al. Aetiology and diagnosis of community acquired
pneumonia and its complicated forms. An Pediatr (Barc) 2011; 76:
162 e1-18.
41. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to
estimate the global burden of pertussis? Lancet Infect Dis 2003; 3:
413-8.
42. Geo F. Brooks, Janet S. Butel, Stephen A. Morse. Microbiología
Médica de Jawetz, Melnick y Adelberg. Edicion: 25ª. Editorial: Mc.
Graw.Hill. 2011. pág. 190-200.
43. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn
WC. Diagnóstico Microbiológico. 6ª ed. Ed. Médica Panamericana
SA. Buenos Aires, 2008 pág. 161-200.
44. Weiser JN, Austrian R. Effect of pneumococcal polysaccharide
vaccine on nonbacteremic pneumococcal pneumonia. Clin Infect
Dis 2007; 44: 1139-40.
45. Hughes JM, La Montagne JR. Emerging infectious disease. J Infect
Dis 1994; 170: 263-4.
46. Hortal M, Ruvinsky R, Rossi A, Agudelo CI, Castañeda E,
Brandileone C, et al. Impacto de Streptococcus pneumoniae en
las neumonías del niño latinoamericano. Rev Panam Salud Pública
2000; 8: 185-95.
47. Trollfors B, Berg S, Backhaus E, Andersson R, Bossen Konradsen
H. Invasive, paediatric, vaccine strains of Streptococcus pneumoniae:
are there differences in clinical characteristics? Scand J Infect Dis
2009; 41: 84-7.
48. Gómez C. Infecciones respiratorias. En: Restrepo A, Robledo J,
Leiderman E, Restrepo IM, Botero D, Bedoya V. Fundamentos
de medicina. Enfermedades infecciosas. 6ª ed. Corporación para
Investigaciones Biológicas, CIB; 2003. p. 138-51.
49. Davey S. Vacunas e inmunización. Situación actual. Organización
Mundial de Salud-OMS. 2003.
resources/files/wwwSOWV_S.pdf.
50. Clark JE, Hammal D, Hampton F, Spencer D, Parker L.
Epidemiology of community-acquired pneumonia in children seen
in hospital. Epidemiol Infect 2007; 135: 262-9.
51. CDC. Progress toward elimination of Haemophilus influenzae type
b invasive disease among infants and children-United States, 1998-
2000. MMWR 2002; 51: 234-7.
52. Goicoechea Sáez M, Fullana Montoro AM, Momparler Carrasco
P, Redondo Gallego MJ, Brines Solanes J, Bueno Canigral FJ.
Enfermedad invasora por Haemophilus influenzae antes y después
de la campaña de vacunación en la población infantil de la
comunidad valenciana (1996-2000). Rev Esp Salud Pública 2002;
76: 197-206.
53. Balboa de Paz F RFJ, Blázquez Gamero D. Neumonía estafi­
locócica. Staphylococcus aureus pneumonia. Acta Pediatr Esp 2008;
66: 111-5.
54. Saldías F, Yáñez J, Saldías V, Díaz O. Community-acquired
pneumonia caused by Streptococcus pyogenes: report of one case.
Rev Med Chile 2008; 136: 1564-9.
55. Crum NF, Russell KL, Kaplan EL, Wallace MR, Wu J, Ashtari P,
et al. Pneumonia outbreak associated with group a Streptococcus
species at a military training facility. Clin Infect Dis 2005; 40: 511-8.
56. Cunningham MW. Pathogenesis of group A streptococcal infections
and their sequelae. Adv Exp Med Biol 2008; 609: 29-42.
57. Enright MC, McKenzie H. Moraxella ( Branhamella) catarrhalis-
clinical and molecular aspects of a rediscovered pathogen. J Med
Microbiol 1997; 46: 360-71.
58. Richards SJ, Greening AP, Enright MC, Morgan MG, McKenzie
H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax
1993; 48: 91-2.
59. Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Moraxella
catarrhalis : from emerging to established pathogen. Clin Microbiol
Rev 2002; 15: 125-44.
60. Doern GV. Branhamella catarrhalis: phenotypic characteristics. Am
J Med 1990; 88 (5A): 33S-5S.
61. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae
and Chlamydia pneumoniae in paediatric respiratory-tract infections.
Lancet Infect Dis 2001;1: 334-44.
62. Carreazo J. Fisiopatología de las infecciones por Mycoplasma
pneumoniae. Paediatrica 2003; 5: 101-8.
63. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical
manifestations, pathogenesis and laboratory detection of
Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008; 32:
956-73.
64. Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae.
Expert Rev Anti Infect Ther 2008; 6: 509-21.
65. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as
a human pathogen. Clin Microbiol Rev 2004; 17: 697-728.
66. Murray HW, Tuazon C. Atypical pneumonias. Med Clin North Am
1980; 64: 507-27.
67. Wolf J, Daley AJ. Microbiological aspects of bacterial lower
respiratory tract illness in children: atypical pathogens. Paediatr
Respir Rev 2007; 8: 212-9.
68. Miyashita N, Niki Y, Nakajima M, Fukano H, Matsushima T.
Prevalence of asymptomatic infection with Chlamydia pneumoniae
in subjectively healthy adults. Chest 2001; 119: 1416-9.
Etiología de las neumonías adquiridas en comunidad en la población infantil - Morales O. et al Neumol Pediatr 2013; 8 (2): 53-65.